PLEASANTON, Calif., Aug. 8, 2023
/PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a
purpose-driven healthcare solutions company at the intersection of
medtech and consumer devices and makers of the Evie Ring,
today announced that it will report second quarter 2023 financial
and operating results on Monday, August 14,
2023. Management will host a conference call and live audio
webcast to discuss these results and provide a business update at
2:00 p.m. PDT (5:00 p.m. EDT).
Attendees can access the live webcast here or on the
investors section of Movano Health's website at
https://ir.movano.com. The conference call can be accessed by
dialing 1-877-407-0989 (domestic) or +1- 201-389-0921
(international). Attendees can also use the Call Me link, in
which they will be dialed in to the conference call instantly on
the number provided with no hold time. An archived webcast will be
available on Movano Health's website approximately one hour after
the completion of the event and for two years thereafter.
About Movano Health
Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health is
developing a suite of purpose-driven healthcare solutions to bring
medical-grade, high-quality data to the forefront of consumer
health devices. Featuring modern form factors, Movano Health's
devices capture a comprehensive picture of a person's vital health
information and uniquely translate the data into personalized and
intelligent insights that empower consumers to live healthier and
more balanced lives. Movano Health's end-to-end solutions will soon
enable consumers and their healthcare professionals to utilize
daily medical-grade data as a tool to proactively monitor and
manage health outcomes. For more information on Movano Health,
visit https://movanohealth.com/.
Forward Looking Statements
This press release contains forward-looking statements concerning
our expectations, anticipations, intentions, beliefs, or strategies
regarding the future. These forward-looking statements are based on
assumptions that we have made as of the date hereof and are subject
to known and unknown risks and uncertainties that could cause
actual results, conditions, and events to differ materially from
those anticipated. Therefore, you should not place undue reliance
on forward-looking statements. Examples of forward-looking
statements include, among others, statements we make regarding
anticipated FDA clearance for the Evie Ring, expected future
operating results; product development and features, product
releases, clinical trial, and regulatory initiatives; our
strategies, positioning and expectations for future events or
performance. Important factors that could cause actual results to
differ materially from those in the forward-looking statements are
set forth in our most recent Annual Report on Form 10-K and any
subsequent Quarterly Reports on Form 10-Q, and in our other reports
filed with the Securities and Exchange Commission, including under
the caption "Risk Factors." Any forward-looking statement in this
release speaks only as of the date of this release. We undertake no
obligation to publicly update any forward-looking statement,
whether written or oral, that may be made from time to time,
whether as a result of new information, future developments or
otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/movano-inc-to-report-second-quarter-2023-financial-results-on-monday-august-14-2023-301896174.html
SOURCE Movano